Comparison of Psoriasis Area and Severity Index (PASI) Scores in Patients Treated with Oral Methotrexate and A Combination of Oral Methotrexate and Narrow Band-Ultraviolet B (NB-UVB) Phototherapy
Open Access
- 30 November 2022
- journal article
- research article
- Published by Universitas Airlangga in Berkala Ilmu Kesehatan Kulit dan Kelamin
- Vol. 34 (3) , 169-173
Abstract
Background: Psoriasis Vulgaris is an autoimmune disease characterized by chronic skin inflammation and epidermal hyperplasia. Psoriasis Area Severity Index (PASI) score is one of the assessments to measure the psoriasis severity. Oral methotrexate is one of the effective therapies for psoriasis patients. Narrow Band-Ultraviolet B (NB-UVB) phototherapy is an adjunctive psoriasis therapy given concurrently with oral methotrexate. Purpose: Determine the difference in Psoriasis Area Severity Index (PASI) scores between Psoriasis Vulgaris patients treated with oral methotrexate and a combination of oral methotrexate and NB-UVB phototherapy. Methods: This observational analytic study was conducted at the Dermatology and Venereology Clinic, Dr. Moewardi General Hospital Surakarta. The patients received oral methotrexate and a combination of oral methotrexate and and Narrow Band-Ultraviolet B (NB-UVB) phototherapy. A retrospective study of medical records was conducted to determine the patient's PASI score before the therapies and 3 months after. All data were analyzed with the Shapiro Wilk normality test and the independent T-test. A p-value was Result: The mean of decreased PASI scores in the oral methotrexate group was (6.00 +2.47) and (6.08 +2.17) in the combination therapy group. Based on the statistical test results from the 24 subjects, it was found that the PASI score decreased (p=0.931). Conclusion: There was no significant difference in the decrease in PASI between the oral methotrexate group and the combination therapy group. The mean reduction of PASI scores was more significant in the combination therapy than in the methotrexate groupKeywords
This publication has 14 references indexed in Scilit:
- The Effect of Systemic Methotrexate and Cyclosporine Combination Therapy inPsoriasis Vulgaris Patients in Bandung, IndonesiaBerkala Ilmu Kesehatan Kulit dan Kelamin, 2021
- National, regional, and worldwide epidemiology of psoriasis: systematic analysis and modelling studyBMJ, 2020
- Metabolic syndrome and psoriatic arthritis among patients with psoriasis vulgaris: Quality of life and prevalenceThe Journal of Dermatology, 2018
- Complementary and integrative therapies for psoriasis: Looking forwardDermatologic Therapy, 2018
- Therapeutic Challenges in a Case of Psoriasis with Nail OnsetJournal of Mind and Medical Sciences, 2017
- Severity of Psoriasis Differs Between Men and Women: A Study of the Clinical Outcome Measure Psoriasis Area and Severity Index (PASI) in 5438 Swedish Register PatientsAmerican Journal of Clinical Dermatology, 2017
- Incidence, prevalence and mortality of patients with psoriasis: a U.K. population-based cohort studyBritish Journal of Dermatology, 2016
- The Patient’s Guide to Psoriasis Treatment. Part 1: UVB PhototherapyDermatology and Therapy, 2016
- Association of Psoriasis With the Risk for Type 2 Diabetes Mellitus and ObesityJAMA Dermatology, 2016
- Efficacy of Methotrexate in patients with plaque type psoriasisPakistan Journal of Medical Sciences, 2014